Attached files
| file | filename |
|---|---|
| EX-31.2 - TearLab Corp | ex31-2.htm |
| EX-23.2 - TearLab Corp | ex23-2.htm |
| EX-32.1 - TearLab Corp | ex32-1.htm |
| 10-K - TearLab Corp | form10-k.htm |
| EX-32.2 - TearLab Corp | ex32-2.htm |
| EX-31.1 - TearLab Corp | ex31-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 Nos. 333-189372, 333-190116 and 333-201355) of TearLab Corp.; and
(2) Registration Statement (Form S-8 Nos. 333-124505, 333-155163, 333-181949, 333-189205, 333-191838, 333-195667, 333-196984, 333-197467, 333-199201, 333-201932 and 333-206757) pertaining to the 2014 Employee Stock Purchase Plan, 2002 Stock Option Plan, as amended, and Nonstatutory Stock Option Agreement of TearLab Corp. (formerly OccuLogix, Inc. and formerly Vascular Sciences Corporation);
of our report dated March 13, 2015, with respect to the consolidated financial statements and schedule of TearLab Corp. included in this Annual Report (Form 10-K) of TearLab Corp. for the year ended December 31, 2015.
| /s/ Ernst & Young LLP |
San Diego, California
March 9, 2016